"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02325089","ORal ApplianCes for sLeep Apnea of the Elderly","ORACLE","Recruiting","No Results Available","Obstructive Sleep Apnea|Hypertension|Cardiovascular Disease","Device: Mandibular advancement device|Device: Placebo","Arterial Blood Pressure Monitoring (ABPM)|Composite measure of Metabolic Syndrome including Glucose, Cholesterol, Triglyceride, Blood pressure, and Waist circumference|Composite measure of Physical Ability|Composite measure of Pain|Quality of life measured by WHOQOL|Circadian rhythm|Composite measure of Cognitive function|Ophthalmological assessment|Heart rate variability|Cost-utility analysis measured by QALY|Change from Baseline Arterial Blood Pressure Monitoring (ABPM) at three months|Change from Baseline Arterial Blood Pressure Monitoring (ABPM) at six months","Hospital de Clinicas de Porto Alegre|Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil|Conselho Nacional de Desenvolvimento Científico e Tecnológico","All","65 Years to 80 Years   (Older Adult)","Phase 4","500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","140069","July 2014","December 2016","December 2020","December 24, 2014","null","March 3, 2016","Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil","","https://ClinicalTrials.gov/show/NCT02325089"
2,"NCT03190850","Effect of Inspiratory Muscle Training","MARITSA","Recruiting","No Results Available","Sleep Apnea, Obstructive","Other: Intervention|Other: Control","Effect of inspiratory exercise on apnea-hypopnea index in elderly patients with sleep apnea.|Effect of inspiratory training on maximal inspiratory and expiratory pressures|Effect of inspiratory muscle training on diaphragm thickness","Hospital de Clinicas de Porto Alegre","All","65 Years to 80 Years   (Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","150276","April 5, 2016","March 9, 2018","May 10, 2018","June 19, 2017","null","June 19, 2017","Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil","","https://ClinicalTrials.gov/show/NCT03190850"
3,"NCT03514199","Mediterranean-type Diet for Older Adults With Obstructive Sleep Apnea","MedOOSA","Not yet recruiting","No Results Available","Sleep Apnea","Other: Mediterranean-type diet|Other: Low fat diet","Apnea-hypopnea index|Body weight|Body composition|glucose|Cholesterol total|LDL-Cholesterol|HDL-cholesterol|Triglycerides","Hospital de Clinicas de Porto Alegre","All","65 Years to 80 Years   (Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","79655917700005327","May 1, 2018","March 31, 2019","December 31, 2019","May 2, 2018","null","May 2, 2018","","","https://ClinicalTrials.gov/show/NCT03514199"
4,"NCT02742792","Effect of Strength Training on Sleep Apnea in the Elderly",,"Enrolling by invitation","No Results Available","Sleep Apnea","Other: Resistance training|Other: Advice on Lifestyle","Apnea-hypopnea index|Muscle strength|Muscle thickness|Muscle quality|Muscle strength of legs|Mobility|Grip strength","Hospital de Clinicas de Porto Alegre","All","65 Years to 80 Years   (Older Adult)","Not Applicable","26","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","15-0613","April 2016","November 30, 2017","December 31, 2017","April 19, 2016","null","October 23, 2017","Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil","","https://ClinicalTrials.gov/show/NCT02742792"
5,"NCT01945801","Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea","DESALT","Completed","No Results Available","Obstructive Sleep Apnea","Drug: Lasilactone|Other: Sodium-Restricted Diet|Drug: Placebo","Apnea-Hypopnea Index|Somnolence scale (Epworth) and ventilatory parameters|Glycolipid profile|Aldosterone Renin Level Activity|Dosages of urinary 24h|Inflammatory marker","Hospital de Clinicas de Porto Alegre","Male","18 Years to 60 Years   (Adult)","Phase 4","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","GPPG-13-0272|13-0272","October 2013","February 2015","February 2015","September 19, 2013","null","August 20, 2015","Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil","","https://ClinicalTrials.gov/show/NCT01945801"
6,"NCT02798367","Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia","Morfeu","Recruiting","No Results Available","Insomnia Disorder","Behavioral: CBT-I plus placebo|Drug: CBT-I plus Melatonin 3 mg|Drug: CBT-I plus Melatonin 5 mg","Change of Sleep Latency after 21 (±2) days of the treatment.|Quality of Sleep - Pittsburgh Sleep Quality Index|Wellness Day - Well-Being Index-5 (WHO-5)|Severity of Insomnia - Insomnia Severity Index|Total Sleep Time - Polysomnography|Sleep Architecture - the length and proportion of N1(non-rapid eyes movement) stages, N2, N3 and REM|Sleep Efficiency - Polysomnography|The Latency of Persistent Sleep - Polysomnography|Latency of REM (rapid eyes movement) Sleep - Polysomnography|Satisfaction of the participants with the treatment.","Ache Laboratorios Farmaceuticos S.A.","All","55 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","307","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","ACH-MSZ-02-03(05/16)","March 22, 2018","December 31, 2019","January 31, 2020","June 14, 2016","null","November 29, 2018","CEDOES - Centro de Diagnóstico e Pesquisa da Osteoporose do Espirito Santo., Vitória, Espírito Santo, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Allergisa Pesquisa Dermato Cosmética Ltda., Campinas, São Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto USP, Ribeirão Preto, São Paulo, Brazil|Centro de Estudos Multidisciplinar CEPES da Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil|Dr Consulta Clinica Medica Ltda, São Paulo, Brazil|Centro Paulista de Investigação Clínica e Serviços Médicos Ltda., São Paulo, Brazil|Centro de Desenvolvimento em Estudo Clínicos Brasil - CDEC Brasil, São Paulo, Brazil","","https://ClinicalTrials.gov/show/NCT02798367"
7,"NCT02270658","Morbidity in Patients With Hypertension and Obstructive Sleep Apnea","MORPHEOS","Recruiting","No Results Available","Hypertension|Sleep Apnea, Obstructive","Device: CPAP","Impact of OSA treatment with CPAP on central blood pressure|Impact of OSA treatment with CPAP on office blood pressure|Impact of OSA treatment with CPAP on 24-h blood pressure|Impact of OSA treatment with CPAP on target-organ damage|Impact of OSA treatment with CPAP on vascular parameters (to be published as a sub-study)|Impact of OSA treatment with CPAP on hypertensive retinopathy and optic nerve damage (to be published as a sub-study)|Validation of portable sleep monitoring to diagnose OSA (to be published as a sub-study)","University of Sao Paulo General Hospital|Financiadora de Estudos e Projetos|Conselho Nacional de Desenvolvimento Científico e Tecnológico","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","3230/08/146","July 2014","July 2018","December 2018","October 21, 2014","null","May 21, 2018","Pronto Socorro Cardiológico de Pernambuco (PROCAPE), Recife, PE, Brazil|Hospital das Clínicas de Porto Alegre, Porto Alegre, RS, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP, Brazil|Fundação Zerbini - Instituto do Coração (InCor), São Paulo, SP, Brazil|Hospital Universitário da Universidade de São Paulo (HU), São Paulo, SP, Brazil","","https://ClinicalTrials.gov/show/NCT02270658"
